First Time Loading...

Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 148.58 USD -0.46% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one JNJ stock under the Base Case scenario is 183.95 USD. Compared to the current market price of 148.58 USD, Johnson & Johnson is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JNJ Relative Value
Base Case
183.95 USD
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
79
vs Industry
30
Median 3Y
5
Median 5Y
4.6
Industry
2.5
Forward
4
More Details
9.3
P/E
P/E
Price to Earnings
9.3
vs History
98
vs Industry
38
Median 3Y
23.1
Median 5Y
22.8
Industry
23.4
Forward
13.7
More Details
15.4
P/OCF
P/OCF
Price to OCF
15.4
vs History
73
vs Industry
28
Median 3Y
18.1
Median 5Y
16.8
Industry
17.4
More Details
47.9
P/FCFE
P/FCFE
Price to FCFE
47.9
vs History
3
vs Industry
13
Median 3Y
20.4
Median 5Y
19.5
Industry
23.6
More Details
5.1
P/B
P/B
Price to Book Value
5.1
vs History
92
vs Industry
14
Median 3Y
5.8
Median 5Y
5.7
Industry
2.1
More Details
4.2
EV/S
EV/S
Enterprise Value to Sales
4.2
vs History
80
vs Industry
30
Median 3Y
5.1
Median 5Y
4.6
Industry
2.6
Forward
4.1
More Details
6.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.1
vs History
87
vs Industry
36
Median 3Y
7.5
Median 5Y
6.9
Industry
5.2
More Details
11.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.5
vs History
93
vs Industry
31
Median 3Y
14.5
Median 5Y
14
Industry
13.7
Forward
11.1
More Details
15
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15
vs History
93
vs Industry
32
Median 3Y
19
Median 5Y
18.9
Industry
17.2
Forward
12.5
More Details
15.6
EV/OCF
EV/OCF
Enterprise Value to OCF
15.6
vs History
76
vs Industry
29
Median 3Y
18
Median 5Y
17.1
Industry
16.2
More Details
19.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.4
vs History
65
vs Industry
22
Median 3Y
21.8
Median 5Y
20.2
Industry
17.8
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
80
vs Industry
31
Median 3Y
2.9
Median 5Y
2.8
Industry
2
More Details

Multiples Across Competitors

JNJ Competitors Multiples
Johnson & Johnson Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Johnson & Johnson
NYSE:JNJ
357.6B USD 4.2 9.3 11.5 15
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
728.7B USD 20.3 118.7 58.1 66.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.7 46.4 34 37
US
Merck & Co Inc
NYSE:MRK
323.1B USD 5.3 140.1 34.9 57
UK
AstraZeneca PLC
LSE:AZN
187.3B GBP 4.9 37.2 174.3 278
CH
Novartis AG
SIX:NOVN
182.7B CHF 4.3 13.6 9.9 16.4
CH
Roche Holding AG
SIX:ROG
175.4B CHF 3 15.3 8.7 10.3
US
Pfizer Inc
NYSE:PFE
159B USD 2.9 -514.5 12.8 20.3
FR
Sanofi SA
PAR:SAN
114.1B EUR 2.4 21.1 8 11.7
P/E Multiple
Earnings Growth
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 50.2
9.3
-20%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
118.7
346%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
46.4
84%
US
Merck & Co Inc
NYSE:MRK
140.1
7 454%
UK
AstraZeneca PLC
LSE:AZN
37.2
168%
CH
Novartis AG
SIX:NOVN
13.6
15%
CH
Roche Holding AG
SIX:ROG
15.3
26%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -514.5
680%
FR
Sanofi SA
PAR:SAN
21.1
120%

See Also

Summary
JNJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JNJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JNJ stock valuation using valuation multiples.
Wall Street Estimates
JNJ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JNJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.